A Phase II Clinical Trial Evaluating the Efficacy and Safety of SYS6026 Injection in Participants With HPV16 or 18-related High-grade Cervical Squamous Intraepithelial Lesions

Clinical trial NCT07702656 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07702656
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High-grade Cervical Intraepithelial Lesions

Start date: 2026-07-10
Primary completion: 2028-09-30
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.